Crinetics Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Crinetics Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 233.19K shares, a 49.59% decline year-over-year.
- Crinetics Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 395.82K shares, a 83.73% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 932.80K shares, a 95.33% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 416.56K shares, a 28.83% decline year-over-year.
- Crinetics Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 2.03M shares, a 11.61% decline from fiscal 2024.
- Crinetics Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 2.29M shares, a 78.83% increase from fiscal 2023.
- Crinetics Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 1.28M shares, a 99.76% decline from fiscal 2022.
- Crinetics Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 524.77M shares, a 44.06% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 233.19K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | 1.98M shares derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | 395.82K shares 10-Q · filed 2026-05-07 | 2.21M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 932.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 2.03M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 416.56K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 1.57M shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 462.58K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 1.74M shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 215.44K shares 10-Q · filed 2025-05-08 | 1.90M shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 477.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 2.29M shares 10-K · filed 2025-02-27 |
| 2024-09-30 | 585.29K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 2.39M shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 625.77K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 2.39M shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 605.08K shares 10-Q · filed 2024-05-09 | 1.86M shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 572.58K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 1.28M shares 10-K · filed 2024-02-28 |
| 2023-09-30 | 584.15K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 524.98M shares derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | 94.06K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 524.47M shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 31.81K shares 10-Q · filed 2023-05-09 | 524.60M shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 524.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 524.77M shares 10-K · filed 2023-02-28 |
| 2022-09-30 | 76.69K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 364.78M shares derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | 226.91K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | 364.70M shares derived: sum of 4 quarters · filed 2022-08-12 |
| 2022-03-31 | 203.05K shares 10-Q · filed 2022-05-12 | 364.48M shares derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-12-31 | 364.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 364.27M shares 10-K · filed 2022-03-30 |
| 2021-09-30 | 85.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | 170.72K shares derived: sum of 4 quarters · filed 2021-11-05 |
| 2021-06-30 | 49.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | 170.67K shares derived: sum of 4 quarters · filed 2021-08-10 |
| 2021-03-31 | 13.00 shares 10-Q · filed 2021-05-06 | 170.67K shares derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-12-31 | 170.58K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | 170.70K shares 10-K · filed 2021-03-30 |
| 2020-09-30 | 35.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | 14.32K shares derived: sum of 4 quarters · filed 2020-11-06 |
| 2020-06-30 | 42.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | 27.39K shares derived: sum of 4 quarters · filed 2020-08-07 |
| 2020-03-31 | 42.00 shares 10-Q · filed 2020-05-08 | 69.15K shares derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-12-31 | 14.21K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | 90.32K shares 10-K · filed 2020-03-09 |
| 2019-09-30 | 13.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 76.12K shares derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-06-30 | 41.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | 135.08K shares derived: sum of 4 quarters · filed 2019-08-13 |
| 2019-03-31 | 21.21K shares 10-Q · filed 2019-05-13 | |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | 479.29K shares 10-K · filed 2019-03-13 |
| 2018-09-30 | 72.07K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 |